Human Microbiome Drugs Global Market Segmentation and key Players Analysis 2024

Pune, India, 14th February 2018: WiseGuyReports announced addition of new report, titled “Human Microbiome-based Drugs and Diagnostics: Global Markets”.

Pune , India - February 14, 2018 /MarketersMedia/ —

Report Scope:
The scope of the study includes the major microbiome-based drugs and diagnostics that are likely to be commercialized within the next eight years. Each product within each market is analyzed to determine its market status, market potential during the time period of 2018 to 2024. Microbiome intellectual property, investments and collaborations are discussed.

Influencing factors, industry structure, challenges facing the industry and patent status are discussed. BCC Research examines companies in the industry, corporate alliances and assay consumption by indication. We profile 25+ companies participating in this rapidly developing and evolving sector.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/reports/2820056-human-microbiome-based-drugs-and-diagnostics-global-markets

Report Includes:
- An overview of the global markets for human microbiome-based drugs and diagnostics.
- Analyses of global market trends, with estimates from 2017, and projections of compound annual growth rates (CAGRs) through 2024.
- Coverage of areas and applications where these technologies are applicable, such as cancer, diabetes, allergic disorders, irritable bowel disorders, celiac disease, and other G.I. disorders.
- An in-depth look at macro-level trends affecting this sector.
- Market intelligence on the technologies and platforms currently being deployed to develop these drugs and diagnostics.
- Specific emphasis on the products in development for various diseases, including the specific forecasts for these products by disease and geography.
- A look at the current level of investments in the sector, intellectual property development, and future of this sector.

Key Players
4D PHARMA
AOBIOME LLC
AVIDBIOTICS INC.
AXIAL BIOTHERAPEUTICS
C3 JIAN INC.
CAELUS HEALTH
DA VOLTERRA
ELIGO BIOSCIENCES
ENTEROME BIOSCIENCES
EVELO BIOSCIENCES
EVOLVE BIOSYSTEMS
METABIOMICS
MICROBIOME THERAPEUTICS
ORIGIN SCIENCES LTD.
OSEL INC.
OXTHERA
REBIOTIX INC.
RITTER PHARMACEUTICALS
SECOND GENOME
SERES THERAPEUTICS
SYMBERIX
SYNLOGIC BIOTICS
SYNTHETIC BIOLOGICS
UBIOME INC.
VEDANTA BIOSCIENCES
VITHERA PHARMACEUTICALS

Table of Content: Key Points
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Chapter 2 Summary and Highlights
Chapter 3 Microbiome Overview
Scientific Background
Human Microbiome in Health and Disease
Advances in Microbiome Research
Focus Areas for Microbiome-Based Drugs and Diagnostics
Microbiome-Based Drugs: Product Development Strategies
Current Challenges in Microbiome Drug Development
Human Microbiome Project
MetaHIT Consortium
Public Sector Initiatives in Microbiome Research
Key Goals of the Human Microbiome Project
Key Achievements of the Human Microbiome Project
Key Goals of MetaHIT Initiative
Chapter 4 Human Microbiome-Based Drugs Market
Cancer
Obesity
Type 2 Diabetes
Ulcerative Colitis and Crohn's Disease
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2820056-human-microbiome-based-drugs-and-diagnostics-global-markets

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +1-646-845-9349

Source URL: https://marketersmedia.com/human-microbiome-drugs-global-market-segmentation-and-key-players-analysis-2024/300923

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 300923

Latest News

Malaysia PM on China, Rohingya, Singapore, graft and sea row

Aug 14, 2018

PUTRAJAYA, Malaysia — Malaysian Prime Minister Mahathir Mohamad commented on lopsided China-backed projects, treatment of Myanmar's Rohingya Muslims, the South China Sea furor, a water treaty with Singapore and the country's financial mess in an interview Monday with The Associated Press. Here are excerpts: ___ AX CHINA-BACKED PROJECTS Days before heading to Beijing for his first visit since his stunning electoral victory three months ago, Mahathir said Malaysia doesn't need a Chinese-backed $20 billion East Coast Rail Link and two energy pipelines worth $2.3 billion. The projects have been suspended pending renegotiation. "We don't think they are viable. So if...

Malaysia eyes more than 10-fold hike in Singapore water deal

Aug 14, 2018

PUTRAJAYA, Malaysia — Malaysia's prime minister said Monday he is seeking to hike the price of water sold to neighboring Singapore by more than 10 times as his country searches for ways to pay off massive debts. Prime Minister Mahathir Mohamad, who shot back to power in an electoral upset in May, told The Associated Press that a decades-old treaty governing the water agreement needs to be revised to reflect increases in the cost of living. The water deal has long been a point of contention between the two countries. Mahathir said in June he wants to renegotiate the deal....

AP Interview: Malaysia's Mahathir aims to scrap China deals

Aug 14, 2018

PUTRAJAYA, Malaysia — Malaysia is looking to cancel multibillion-dollar Chinese-backed infrastructure projects signed by the previous scandal-tainted government as it digs itself out of debt, Malaysia's prime minister said Monday during an extensive interview in which he also blasted Myanmar's treatment of Rohingya Muslims as "grossly unjust." Mahathir Mohamad, at 93 the world's oldest prime minister, spoke with The Associated Press days before he heads to Beijing for his first visit since returning to power in a stunning electoral upset three months ago. Mahathir said he wants to maintain good relations with China and welcomes its investment, so long as...

Death toll from quake that hit Indonesian island passes 430

Aug 14, 2018

JAKARTA, Indonesia — The death toll from the earthquake that rocked the Indonesian island of Lombok a week ago has passed 430 and the government is estimating economic losses will exceed several hundred million dollars. The national disaster agency said Monday the Aug. 5 quake killed 436 people, most of whom died in collapsing buildings. It said damage to homes, infrastructure and other property is at least 5 trillion rupiah ($342 million), calling that a temporary figure that will rise as more assessments are made. The agency said rebuilding will cost hundreds of millions of dollars. The magnitude 7.0 quake...

Malaysia ex-PM pleads not guilty to money laundering charges

Aug 14, 2018

KUALA LUMPUR, Malaysia — Former Malaysian Prime Minister Najib Razak pleaded not guilty Wednesday to three new money-laundering charges related to the alleged multibillion-dollar looting of a state investment fund that led to his stunning electoral defeat three months ago. Dressed in a grey suit, Najib was calm and spoke softly as he entered his plea in the High Court. He has previously accused Malaysia's new government of seeking political vengeance and vowed to clear his name in his trial. Najib, 65, had pleaded not guilty last month to abuse of power and three counts of criminal breach of trust....

About Us

Pioneered by experienced entrepreneurs, bankers and software engineers, BursaKL stand tall to bring you the latest state of business and finance from Malaysia and all over the world.

Contact us: sales[at]bursakl.com